Your browser does not have JavaScript enabled and some parts of this website will not work without it.
For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
We use cookies to make our site as useful as possible.
Our Cookie Policy explains how you can opt-out of the cookies we use.
If you continue without changing your cookie settings, we'll assume you’re happy with this.
Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.
Full event breakdown with abstracts, speakers, registration and more
Join Dr Arturas Volianskis of Queen Mary University of London as he reviews current knowledge of synaptic plasticity, compares the processes of long-term potentiation (LTP) and long-term depression (LTD), and discusses the future of NMDAR research .
Dr Arturas Volianskis attended Vytautas Magnus University in Kaunas, Lithuania where he earned a degree in humanities. He further completed research degrees in Philosophy (MA) and Medicine (PhD) from the University of Aarhus, Denmark in 2002.
After finishing his degrees, he joined the lab of Professor Morten S. Jensen as an assistant professor. In 2006, he joined the research groups of Professors Graham L. Collingridge and David E. Jane at the University of Bristol, UK, where he investigated synaptic plasticity and contributed to the development of new pharmacological tools.
Arturas has recently been appointed as Lecturer in Neuroscience, at Queen Mary University of London, UK. He currently studies NMDARs and their involvement in synaptic plasticity.